Pharma Foods International Co., Ltd. (TYO:2929)
677.00
-11.00 (-1.60%)
Jan 21, 2026, 3:30 PM JST
TYO:2929 Revenue
Pharma Foods International had revenue of 15.71B JPY in the quarter ending October 31, 2025, with 7.65% growth. This brings the company's revenue in the last twelve months to 66.38B, up 9.53% year-over-year. In the fiscal year ending July 31, 2025, Pharma Foods International had annual revenue of 65.26B with 5.01% growth.
Revenue (ttm)
66.38B
Revenue Growth
+9.53%
P/S Ratio
0.30
Revenue / Employee
108.28M
Employees
613
Market Cap
19.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2025 | 65.26B | 3.11B | 5.01% |
| Jul 31, 2024 | 62.15B | -6.43B | -9.37% |
| Jul 31, 2023 | 68.57B | 8.39B | 13.94% |
| Jul 31, 2022 | 60.19B | 13.43B | 28.73% |
| Jul 31, 2021 | 46.75B | 31.40B | 204.51% |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 62.05B |
| Fuji Pharma | 51.68B |
| Daito Pharmaceutical | 51.20B |
| Koa Shoji Holdings | 24.19B |
| Morishita Jintan | 12.90B |
| Mizuho Medy | 9.67B |
| Wakamoto Pharmaceutical | 9.43B |
| Taiko Pharmaceutical | 5.94B |